Duke Angel Network
VC Fund
Durham, United States
Duke Angel Network is a VC fund in Durham focused on Artificial Intelligence and Medical. Duke Angel Network leverages the Duke network to help investors find innovative early-stage companies with great teams, and their entrepreneurs find access to smart capital to fuel their growth. Their mission is to support the global Duke entrepreneurial community with an angel investing platform and co-investment fund (the Duke Innovation Fund)that engages and leverages the power of the Duke alumni network. The Duke Angel Network operational team and investment platform exist within the Duke Innovation and Entrepreneurship Initiative.The Duke Angel Network actively engages and matches Duke alumni network expertise with portfolio companies to support growth and success. The global Duke community offers a uniquely powerful opportunity for networking and guidance from industry experts and successful entrepreneurial leaders. Duke Angel Network members work actively to connect their portfolio companies with the Duke network to foster collaboration and further success.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 7%
Last updated:
For AI agents: llms.txt
Industries Duke Angel Network invests in
Stages Duke Angel Network invests in
Countries Duke Angel Network invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Artificial Intelligence 8 (18%)
- Medical 7 (16%)
- Software 7 (16%)
- Health Care 7 (16%)
- Medical Device 7 (16%)
Stage
- Seed 18 (40%)
- Series A 13 (29%)
- Series B 3 (7%)
- Pre-Seed 2 (4%)
- Funding Round 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Phillip Graham
Associate Director
|
Associate Director | Total investments: 0 | Find email | |
Salman Azhar
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
Kurt Schmidt
Executive-In-Residence
|
Executive-In-Residence | Total investments: 7 | Find email | |
Pamela Hawley
Investor
|
Investor | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Pryon is an artificial intelligence company focused on enterprise knowledge management. Its natural language processing platform transforms unstructured data into experiences that increase productivity with unmatched accuracy and speed. Pryon’s automated machine learning engines deliver rapid time to value by enriching existing content. Thisno-code approach prevents operational disruption and allows organizations to quickly maximize the business value trapped within their information assets. Pryon was founded by Igor Jablokov, whose previous company defined the state of the art for AI assistants and was acquired by Amazon to form the basis for Alexa. | $19.6M / Venture - Series Unknown / Jan 11, 2023 | ||
| Atmos develops a home-building platform to assist in the creation and design of customized houses. The company is constructing a managed marketplace for homebuilding, connecting home buyers.The company's platform makes it easier for customers to find and build their own homes according to their preferences, choices, and financial situationby offering a variety of designs, personalized packages, and interiors along with financing and construction processes.Atmos was established in 2018 by Trent Hedge, Nicholas Donahue, Matthew Rastovac, and Austin Kahn. | $12.5M / Series A / Nov 15, 2022 | ||
| Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster. It was founded in 2019 and is headquartered in Durham,North Carolina. | $19M / Series A / Jul 13, 2022 | ||
| AiFi's platform uses computer vision and real-time sensor intelligence to understand how people, objects, and environments interact within a physical space. By creating a continuously updated spatial understanding of the environment, AiFi allows physical locations to perceive, reason, and respond in real time.AiFi’s technology powersapplications such as frictionless checkout, real-time inventory awareness, and operational insights in retail environments. Beyond retail, the platform is designed to be extensible to any physical space where understanding movement, behavior, and context is critical. By bridging the gap between the digital and physical worlds, AiFi helps organizations operate more efficiently, improve user experiences, and unlock new ways of interacting with physical environments.At its core, AiFi transforms physical spaces into software-defined environments by making them measurable, adaptable, and intelligent. | $65M / Series B / Mar 11, 2022 | ||
| InSoma Bio integrates biology and materials science that solve problems in tissue engineering and regenerative medicine. It offers reconstructive plastic surgeries and injectable materials. InSoma Bio was founded in 2018 by Stefan Roberts and Ashutosh Chilkoti and was headquartered in Carolina, United States. | $1.8M / Pre-Seed / Jan 01, 2022 | ||
| Sparta Biomedical develops cartilage-like implants for the knee. They specialise in the creation of biomimetic implants that require minimally invasive therapy for chondral or osteochondral knee cartilage abnormalities, providing orthopaedic surgeons with enhancements that fundamentally restore movement for their patients. | $5M / Seed / Dec 14, 2021 | ||
| Embrace is the only user-focused observability platform that ties technical performance to end-user impact. Powered by OpenTelemetry, Embrace provides Real User Monitoring (RUM) across mobile and web, giving engineering teams the visibility and context they need to prioritize and resolve issues faster, optimize performance, and deliver exceptionaldigital experiences.Embrace is a member of the Cloud Native Computing Foundation (CNCF) and contributes to several OpenTelemetry Special Interest Groups (SIGs). Embrace counts AllTrails, Amazon, Cameo, GOAT, Hyatt, The New York Times, and many more as customers. Supported by NEA, AV8 (Allianz), Greycroft, and Eniac, Embrace is a YCombinator (YC Growth) company based in Los Angeles, Palo Alto, Buenos Aires, and London. | $45M / Series B / Oct 20, 2021 | ||
| Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster. It was founded in 2019 and is headquartered in Durham,North Carolina. | $70M / Series A / Jul 08, 2021 | ||
| Realtime Robotics is a developer of a specialized processor for generating safe robot motion plans in micro-seconds. They are transforming automation in its broadest sense by enabling machines to recognize, respond and decide how and where to move in milliseconds, even in variable environments. Their RapidPlan processor harnesses cutting-edgecomputer processing and software to end the trade-off between speed and safety that’s holding automation back today.Realtime Robotics is resolving these limitations with specialized hardware enabling fast, collision-free motion in unstructured environments, enabling vastly broader applications of robotics in industry, and autonomous vehicles that drive naturally, enabling more rapid adoption and proliferation. | $31.4M / Series A / Jun 03, 2021 | ||
| Otter.ai offers a collaborative note-taking app that makes important information from voice conversations including meetings, interviews, and lectures instantly accessible and actionable. Otter Voice Notes is used by business professionals, journalists, and students to generate rich, easily searched, and shared notes. Otter is based on proprietarytechnologies for speech recognition, speaker separation, speaker ID, and keyword/topic extraction. | $40M / Series B / Feb 25, 2021 | ||
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Duke Angel Network invest in?
Duke Angel Network invests primarily in Artificial Intelligence, Medical and Software startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Duke Angel Network?
Public channels for Duke Angel Network include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Duke Angel Network?
The team at Duke Angel Network includes Phillip Graham (Associate Director), Salman Azhar (Managing Director) and Kurt Schmidt (Executive-In-Residence). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
